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CASE REPORT

Open Access

Autoimmune enteropathy with a CD8+ CD7T-cell small bowel intraepithelial lymphocytosis:
case report and literature review
Shrinivas Bishu1*, Violeta Arsenescu2, Eun Y Lee4, H David Vargas3, Willem JS de Villiers2 and Razvan Arsenescu2

Abstract
Background: Adult onset autoimmune enteropathy (AIE) is a rare condition characterized by diarrhea refractory to
dietary therapy diagnosed in patients with evidence of autoimmune conditions. Auto-antibodies to gut epithelial
cells and other tissues are commonly demonstrated. Despite increasing awareness, the pathogenesis, histologic,
immunologic and clinical features of AIE remain uncertain. There remains controversy regarding the diagnostic
criteria, the frequency and types of auto-antibodies and associated autoimmune conditions, and the extent and
types of histologic and immunologic abnormalities. CD4+ T-cells are thought to at least responsible for this
condition; whether other cell types, including B- and other T-cell subsets are involved, are uncertain. We present a
unique case of AIE associated with a CD8+CD7- lymphocytosis and review the literature to characterize the
histologic and immunologic abnormalities, and the autoantibodies and autoimmune conditions associated with
AIE.
Case Presentation: We present a case of immune mediated enteropathy distinguished by the CD8+CD7- intraepithelial and lamina propria lymphocytosis. Twenty-nine cases of AIE have been reported. The majority of patients
had auto-antibodies (typically anti-enterocyte), preferential small bowel involvement, and predominately CD3+ CD4
+ infiltrates. Common therapies included steroids or immuno-suppressive agents and clinical response with
associated with histologic improvement.
Conclusions: AIE is most often characterized (1) IgG subclass anti-epithelial cell antibodies, (2) preferential small
bowel involvement, and (3) CD3+ alphabeta TCR+ infiltrates; there is insufficient evidence to conclude CD4+ T-cells
are solely responsible in all cases of AIE.

Background
Immune enteropathies are heterogeneous group of rare
conditions characterized by intractable diarrhea, damage
to intestinal epithelia and constituent cells, and villous
atrophy. These enteropathies may be associated with
primary immune deficiencies (PIDs) such as the
immune dysregulation, polyendocrinopathy, enteropathy,
X-linked (IPEX) syndrome, common variable immune
deficiency and selective IgA deficiency, or may occur in
patients with auto-immune phenomena in the absence
of PIDs where it is termed auto-immune enteropathy
(AIE) [1].
* Correspondence: shrinivas@uky.edu
1
Department of Internal Medicine, University of Kentucky Medical Center,
800 Rose Street, Lexington, Kentucky, 40536, USA
Full list of author information is available at the end of the article

Typically, the diagnosis of immune mediated enteropathy in the setting of PIDs is clear from the clinical
features and a pre-existing diagnosis of PID. In contrast,
AIE may be diagnosed in patients with no evidence of
PIDs, intractable diarrhea refractory to exclusion diets,
and no evidence of celiac disease [1].
Cumulatively, immune enteropathies, including AIE,
have an unclear pathogenesis. They are all thought to be
mediated by immune phenomena, either through direct
damage to gut epithelial cells by auto-reactive cells
(IPEX) or auto-antibodies (AIE), or from a propensity
for bowel infections (IgA deficiency). However, the exact
cell types causing damage and the mechanisms of disease remain unclear in many of these conditions.
Herein, we report a patient with an immune mediated
enteropathy distinguished from previously reported
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cases by an unusual CD8+ CD7- IEL in the absence of a
PID. We also review the literature to characterize the
histologic and immunophenotyic features of AIE, which
our patient’s enteropathy most closely resembles.
Case Presentation

The patient was a 28 year old Asian Indian female of
non-consanguineous parents who presented with a 3
year history of non-bloody diarrhea with abdominal
cramping. Past medical history was significant for hepatitis A. She denied alcohol or tobacco use, had no
chronic medical conditions, was not on any medications
including gut irritants such as aspirin/non-steroidials
and did not have a history of travel prior to onset of
symptoms. Her last travel was to India one year prior to
presentation, but she did not report any alleviation or
exacerbation of her symptos with the travel/dietary/
environmental change. She weighed 81 pounds at presentation. Stool cultures were negative for pathogens.
Basic labs, including the erythrocyte sedimentation rate
and C-reactive protein were normal, but liver function
tests (LFTs) were elevated (Table 1). Abdominal computed tomography (CT) revealed hepatic hypodensities
and mesenteric adenopathy. Serology was negative for
anti-nuclear (ANA) and anti-smooth muscle antibodies
as well as antibodies for cytosolic anti-neutrophil cytoplasm (cANCA), liver-kidney microsomes, liver cytosolic
and soluble liver-pancreas antigen. However, pANCA
was positive (titer: > 1:20) and she had hyper-gammaglobulinemia (IgG: 2358 (630-1580 mg/dl), IgA: 578
(100-400 mg/dl), IgM: 134 (37-247 mg/dl). Serum ceruloplasmin was normal, and serology for hepatitis B and
C were negative. Serum B12, folate and hematocrit were
normal.

Histologic examination of intestinal mucosa demonstrated chronic inflammation with duodenal intraepithelial cell lymphocytosis (IEL) (Table 1) (Figure 1). Celiac
disease and tropical sprue were therefore considered
based on the clinical features and IEL. However, tissue
transglutaminase (TTG) IgA was normal (5.3, reference:
< 7.0 AU), as were anti-enterocyte antibodies (only IgA
tested) (both measured by enzyme linked immunoabsorbant assay of serum). Indirect immunofluorescence
on human intestinal tissue samples was not performed.
The patient refused liver biopsy, but permitted CT
guided biopsies of the enlarged retroperitoneal and periportal nodes; histologic analysis only demonstrated normal stroma. She was diagnosed with auto-immune
hepatitis (AIH) based on her revised original International AIH group score of 12 (indicating probable AIH
by criteria)[2].
Over the next 21 months, she continued to have diarrhea despite dietary exclusion therapy, and elevated
LFTs (Table 1). Because serum folate and B12 remained
withing normal limits for the duration of her care, she
was not treated with these agents. She did develop a
mild iron deficiency anemia, but never required blood
transfusions. Endoscopy 15 months after presentation
demonstrated progression with grossly friable duodenal
mucosa. There was marked IEL with a CD8+ T-cell subset without evidence of enteropathy type T-cell lymphoma (Figure 2). Flow cytometry revealed a nearly
100% T-cell preponderance, the majority of which were
a polyclonal ab T-cell receptor (TCR)+ CD8+ CD7- subset (Table 1: 15 months). Clonality was assessed by polymerase chain reaction of TCR chains. The minority of
IELs were CD4 + and CD8 + CD7 + subsets; there were
normal numbers of intra-epithelial gδ T-cells and rare

Table 1 Liver function test and histologic features pre- and post-prednisone
Pre-prednisone
Presentation

15 months

Post-prednisone
21 months

26 months

Liver Function Tests
AST (U/L)

107

43

41

65

ALT (U/L)
ALP (U/L)

95
240

46
205

97
110

82
123

Albumin (g/
dL)

2.2

1.5

2.1

3.5

Histology
Histology

IEL
Intact villi
Chronic
inflammation

Intact villi
Duodenum + jejunum+ illeum:
lymphoplastic infiltrate
Colon + cecum + rectum:
lymphoplastic infiltrate

Immunophenotype

not obtained Jejunum + illeum: CD3+CD5+CD8
+
CD7-preponderance

IEL
Subtotal villous atrophy

IEL
Subtotal villous atrophy Segmental areas normal

Jejunum: Polyclonal abTCR
+
CD3+ preponderance
CD8+CD25-CD7- (70% of total
IEL)

Jejunum: Polyclonal abTCR+CD3+ (94% of total IEL)
CD8+CD25-CD7- (41% of CD3+ fraction)
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Figure 1 Duodenal biopsy at presentation demonstrating regions of IEL (large arrow) with normal appearing LP (small arrow) and
interspersed areas of villous blunting (*).

B-cells (CD20+). Biopsies samples from the stomach and
esophagus were normal, as was colonoscopy. There was
no evidence of reduced numbers or abnormal morphology of epithelial or goblet cells.
Because of the marked IEL without laboratory or histologic evidence of celiac disease, she was treated with
Ciprofloxicin® and Metronidazole® for potential bowel
overgrowth and/or tropical sprue. However, six months
of antibiotic therapy did not result in clinical or histologic improvement (Table 1: 21 months). Although refractory celiac disease is possible in this scenario, but the
lack of elevated intra-epithelial gδ T-cells, normal TTG
IgA, and her negative HLA-DQ2/DQ9 genotype make
this unlikely. A diagnosis of an immune mediated
enteropathy was therefore considered based on the lack
of clinical or histologic response to dietary and antibiotic therapy, and the lack of celiac disease serologic markers. Prednisone (60 mg) daily was started.
Steroid therapy resulted in marked improvement with
symptom resolution accompanied by a 20 lb weight

gain. She remained in clinical remission 4 weeks after
therapy when repeat Endoscopy demonstrated persistent
IEL, but a reduction in the CD8+CD7- fraction to 41%
of total CD3+ cells (Table 1: 24 months). Histologically,
regions with normal villi were now interspersed with
abnormal regions (Figures 3 and 4). Her LFTs remained
elevated despite the clinical remission and histologic
improvement. The patient decided against maintenance
therapy with prednisone or azathioprine because she
wanted to get pregnant.
Literature Review

At least 29 cases of AIE have been reported, of which,
26 meet the original diagnostic criteria for AIE [3-9]
(Table 2). Eighty five percent (22/26) had anti-epithelial
cell antibodies (anti-enterocyte (AEA): n = 17 (65%),
anti-goblet cell (AGC): n = 7 (27%), or both: n = 2
(8%)), which were of the IgG class in 76% (13/17) with
AEA and 100% (7/7) with AGC. The remaining four
patients without antibodies had at least one
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Figure 2 Duodenal biopsy before steroid therapy demonstrating regions with persistent IEL (large arrow) with marked LP
lymphocytosis (small arrow).

autoimmune condition (Table 2). Hypothyroidism was
most frequently reported, but no disorder was strongly
associated with AIE. The majority (69%) had other circulating tissue auto-antibodies, most commonly, ANA
(Table 2).
Fourteen studies detailed the sites of disease, and 9
provided some immuno-phenotypic analysis (Table 3).
The small bowel was the most frequently involved (79%
of cases), followed by the colon and stomach. Six (43%)
patients had multiple sites and two had extensive disease
(stomach, small intestinal and colonic disease) (’generalized autoimmune gut disorder’)[5,10,11]. Nine patients
(75%) had small bowel IEL at presentation while at least
one case reported concurrent colonic IEL. Complete or
partial clinical response with therapy was associated
with improved IEL in all 8 cases that reported these
findings [5-9,11,12]. The IEL was predominantly T-cells
(CD3+) in at least three cases, and was furthermore CD8
+
in at least one of these. T-cell (CD3+) lymphocytosis
was also reported in the lamina propria in four of five

cases that provided this data (Table 3). One case
demonstrated extensive abnormalities in CD4+ T-cells,
including increased tumor necrosis factor (TNF)a production from activated rectal lymphocytes [5]. However,
this finding must be cautiously extrapolated because
that patient had active CMV colitis and it is therefore
possible that the TNFa response represent
epiphenomena.

Discussion
We report a patient with an enteropathy associated
with an aberrant CD8+CD7- T-cell IEL. Clinically, on
histology and by flow cytometry, our patient had characteristic features of an immune mediated enteropathy.
The abberant T-cell subset in our patient was reproducible, polyclonal, and correlated with the presence of
clinical symptoms. Moreover, the symptom resolution
and weight gain with steroid therapy correlated with
improvement in villous architecture and a decrease in
the CD8 + CD7 - T-cell subset. These facts strongly
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Figure 3 Duodenal biopsy 4 weeks after completing steroid therapy obtained during symptom resolution demonstrating normal
tissue (IEL and LP compartments marked by large and small arrows, respectively).

argue that the T-cell subset was at least partially
involved in our patient’s enteropathy and was potentially causative, especially considering the failure of
dietary exclusion, antibiotics and other therapies in
inducing clinical, histologic or immunologic improvement. The salient feature of our case therefore remains
the aberrant CD8+CD7- IEL in the absence of abnormalities in CD4 + or NK cells as have been previously
reported in AIE [5,13].
CD7 is a member of the immuno-globulin superfamily
and is expressed on most thymocytes and early in the
ontogeny of T- and NK-cells where it is thought to participate in intracellular signaling [14]. The majority of
peripheral T-cells in adults bear CD7, but CD7- T-cells
are a normally circulating minority comprising 9% of all
peripheral blood monocytes (PMBC). The majority of
CD7- T-cells are CD4+ (8% of PMBC) with CD8+CD7cells accounting for the remaining 1% of PMBC (CD4
+
/CD8+ ratio = 8)[15]. Although the exact function of
CD7- T-cells is uncertain, they appear to be terminally
differentiated, activated T-cells. Stimulated CD4+CD7-

T-cells produce high levels of interleukin-2 and gamma
interferon, and compared with CD7+ subsets, have augmented proliferative responses to protein antigens [15].
Furthermore, CD7- T-cells express higher levels of activation markers including CD45RO and CD25 compared
with their CD7 + counterparts [15]. CD7 - T-cells may
also play a role in autoimmune disease evidenced by the
increased CD4+CD7- cell expansion and accumulation
reported in rheumatoid arthritis [16] and psoriasis [17].
These data suggest that the CD8+CD7- subset demonstrable in our patient were activated cells that were
potentially causative.
The diagnosis of AIE requires the presence of autoimmune phenomena, typically taken to be circulating
auto-antibodies to intestinal epithelial cells and/or the
presence of auto-immune disease(s) in the absence of
celiac disease or PIDs. Our patient had no evidence of
anti-epithelial cell antibodies, and in the absence of her
diagnosis of AIH, had no other auto-immune conditions. Moreover, her diagnosis of AIH, although based
on accepted guidelines, is suspect as she had “auto-
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Figure 4 Duodenal biopsy obtained at the same time as in figure 3, but from a different region demonstrating abnormal tissue with
blunted architecture (IEL and LP compartments marked by large and small arrows, respectively).

antibody negative” AIH, a low pANCA titer, and no
liver biopsy [2]. Notably the classical AIE criteria remain
controversial, with alternative suggestions to limit the
AIE to only those with demonstrable anti-gut epithelial
cell antibodies or refine the diagnosis based on histologic immuno-phenotypic characteristics [5]. Regardless of
whether our patient meet criteria for AIE, the cumulative evidence suggest our patient had an immune
mediated enteropathy. This conclusion is further bolstered by the reduced fraction of CD8+CD7- cells concurrent with clinical improvement on prednisone
therapy.
Our review finds that AIE is most often characterized
by (a) IgG subclass anti-epithelial cell antibodies, (b)
preferential small bowel Involvement, and (c) CD3+ ab
TCR+ intra-epithelial and lamina propria lympocytosis.
A protean set of histologic abnormalities have been
reported, including: villous atrophy, absence of goblet
and paneth cells [3,4,18], IEL and infiltrates into the
lamina propria (LP). The clinical features and

therapeutic response of those with AIE but without
anti-epithelial cell antibodies [4,10,19,20] appears indistinguishable to those with antibodies. While the data
suggest AIE is associated with a CD3 + T-cell intraepithelial and lamina propria lymphocytosis, it must be
judiciously interpreted due to the paucity of cases that
reported immuno-phenotypic findings, and because CD3
+
cells are the dominant subtypes in these compartments. CD4+ T cells are thought to be at least partially
responsible for AIE based on (a) the phenotypic similarities between AIE and the IPEX syndrome [21,22], (b)
the role of CD4+ T cells in villous atrophy [23] and (c)
the aberrant CD4 + T cell subsets and CD4 + IEL
reported in some cases of AIE [5]. Despite these points,
our review suggests that, at present, there is insufficient
evidence to definitively confirm or refute this hypothesis
in adult onset AIE. It also remains possible that AIE is
the common phenotypic result of a heterogeneous set of
mechanistic abnormalities rather than a single unified
condition.

Reference

Gender,
Age

Anti-Enterocyte
antibodies

AntiGoblet cell
antibodies

Auto-antibodies

Auto-immune
involvement

Immune abnormalities

16

F, 38

IgA and IgG

16

F, 47

IgA and IgG

NR

-

NR

NR

NR

Anti-actin
Anti-parietal
Anti-thyroid microsomal
Anti-thyroid microsomal Antithyroglobulin

NR

NR

8

F, 39

+

NR

ITP
Raynaud
Hepatitis
Cholangitis

Impaired antibody production to mitogens and protein
antigens

19

F, 50

IgG

NR

Perivisceritis
Food allergies

NR

18

F, 82

IgG

NR

NR

NR

NR

20

M, 67

NR

NR

NR

NR

NR

20
22

F, 39
F, 58

NR
-

NR
NR

NR
Anti-parietal cell
ANCA
Anti-thyroglobulin
Anti-thyroid peroxidase

NR
CD4+ lymphopenia
Granulocytopenia

15

M, 54

+

NR

pANCA
ANA

NR
T- and B-cell pulmonary
infiltrate
Autoimmune thyroiditis
Sicca syndrome
Polyneuropathy
Pancreatitis (possible)
Autoimmune neutropenia
NR

3

M, 19

-

IgG

NR

Collagenous enterocolitis
Elevated liver enzymes
Elevated pancreatic
enzymes
Atopic dermatitis
Uveitis
Hyperthyroidism

NR

17

F, 35

IgA and IgG

NR

Anti-CCP
ANA

Rheumatoid arthritis

NR

21

M, 59

NR

NR

Anti-intrinsic factor

Pangastritis (atrophic)

NR

4

M, 21

NR

NR

RF
ANA

Elevated IgG
Low IgA

24

M, 58

+

NR

Anti-parietal cell
Anti-thyroid globulin
Anti-thyroid peroxidase
Anti-adrenal cortical

Autoimmune hemolytic
anemia
Hypothyroidism
Raynaud
Exfoliative dermatitis
NR

23

M, 37

IgG

-

ANA

Pancreatic insufficiency

NR

-
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23

M, 75

IgG

IgG

Anti-acetylcholine receptor
Anti-striated muscle
Anti-glutamic acid dehydrogenase

Myasthenia gravis
Thymoma
Autoimmune myopathy
Autoimmune
gastroenterocolitis

NR

23

F, 46

-

IgG

-

Psoriatic arthritis

NR

23

F, 42

-

IgG

-

Atopic dermatitis
Autoimmune
gastroenterocolitis

NR

23

F, 38

-

IgG

Anti-parietal cell

Pancreatic insufficiency
Autoimmune
gastroenterocolitis

NR

23

F, 76

IgG

-

ANA

NR

hypogammaglobulinemia (low IgG and low IgM)

23

M, 55

-

-

-

NR

CVID

23

M, 40

IgM

-

ANA

NR

CVID

23

M, 54

-

IgG

-

NR

CVID

23

M, 67

IgA and IgG

-

-

NR

Polyclonal hypergammaglobulinemia

23

F, 45

IgG

IgG

Anti-SSA
Anti-phospholipid

Sjogren’s
RA
Raynauds
Refractory sprue
Lymphocytic colitis

NR

23

M, 59

IgG

-

ANA

Autoimmune
gastroenterocolitis

NR

23

M, 75

NR

NR

Anti-saccharomyces cerevisiae
antibodies

Autoimmune
gastroenterocolotis

Polyclonal hypergammaglobulinemia

23

F, 61

IgG

-

pANCA
ANA

Hypothyroidism
Refractory sprue

NR

23

F, 59

IgG

-

ANA

Lymphocytic colitis
Hypothyroidism

NR
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Table 2 Reported Cases and Auto-Antibodies (Continued)

Abbreviations:
ANA: anti-nuclear antibody
ANCA: anti-neutrophil cytoplasmic antibody (p: protoplasmic)
Anti-CCP: anti-cyclic citrullinated peptide antibody
CVID: common variable immune deficiency
ITP: idiopathic thrombocytopenic purpura
RF: rheumatoid factor
NR: not reported

Page 8 of 10

Bishu et al. BMC Gastroenterology 2011, 11:131
http://www.biomedcentral.com/1471-230X/11/131

Page 9 of 10

Table 3 Reported Cases with Sites of Disease and Histologic Findings
Reference Gender,
Age

Involved sites

Intra-epithelial

Lamina propria

16

F, 38

Small intestine

46%a

NR

16
8

F, 47
F, 39

Small intestine
Stomach, duodenum,
jejunum, colon, rectosigmoid

42%a
a
12% (normal), decreased CD3- CD103+, aberrant CD3
+
CD4+CD103-, increased HLA-II expression on CD3+

NR
Lympho-plasmacytic infiltrate (CD3+)

19

F, 50

Duodenum, colon

Duodenum: IEL = 48/100, CD3+ 50/mm (elevated),
eosinophils (some);
Colon: normal

Colon: lympho-plasmacytic infiltrate,
eosinophils (some)

18

F, 82

Duodenum

Lympho-plasmacytic infiltrate

NR

20

M, 67

colon

NR

NR

20
22

F, 39
F, 58

Small intestine, colon
Stomach, duodenum,
jejunum, colon,
rectosigmoid

NR
Duodenum: IEL = 10-20/100, CD8+ preponderance
Jejunum: lymphocytosis
Colon: chronic inflammation, CD4+, CD8+, CD19+/20+,
CD68+

NR
Duodenum: CD3+ and CD43+
lymphocytosis with CD68+ (macrophages)
Jejunum: Inflammatory infiltrate

15

M, 54

Duodenum, ileum

Duodenum: IEL = 28/100 (normal), 50% CD8+,
oligoclonal TCR ab+
Ileum: lymphocytosis
Colon: lymphocytosis
Normal

NR

3

M, 19

Duodenum, ileum, colon

17

F, 35

Duodenum

IEL = > 40/100
52% CD3+

NR

NR

21

M, 59

Stomach, colon, ileum

Normal

4

M, 21

Duodenum

24

M, 58

Duodenum, ileum, colon

IEL = 50/100
CD8+ preponderance
Lymphocytosis

Colon + Ileum: lympho-plasmacytic
infiltrate, occasional neutrophils and
eosinophils
Stomach + Colon + Ileum: CD8+ and
CD45RO+ preponderance
+
CD4 preponderance, occasional CD8+
and neutrophils, rare CD20+
Lympho-plasmacytic infiltrate

Abbreviations:
IEL: Intra-epithelial lymphocytosis
a: expressed as a percentage of total cells

Conclusions
Our patient likely had an auto-immune enteropathy
associated with an aberrant CD8+CD7- T-cell IEL. Our
review of adult onset AIE suggest that the most common features are the presence of IgG type anti-gut
epithelial antibodies and preferential small bowel
involvement.
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